What the preservation window usually means

Rather than tying the "preservation window" to a research checklist, the practical answer is simpler: many people with early knee pain, stiffness, swelling or crepitus may still be in a stage where joint-preserving assessment is worthwhile, so long as the knee is not already showing the end-stage picture of collapse, major loss of function or severely worn joint surfaces. In published knee-OA work, that window is usually framed as an early or mild-to-moderate phase, not as a formally standardised disease stage with a single validated cut-off.

One reason the boundary stays blurred is that normal or only mildly abnormal X-rays — sometimes even Kellgren–Lawrence 0–I — do not rule out meaningful cartilage, meniscal or bone-marrow change, while mild imaging changes do not automatically prove osteoarthritis is the cause of pain. A 2025 OARSI differential-diagnosis paper also underlined that meniscal injury, patellofemoral pain, collateral ligament injury, immune-mediated arthritis and crystal arthritis can all mimic early OA symptoms. In practice, the preservation question is whether there is still a potentially treatable driver — early degenerative change, a focal cartilage lesion or load-related malalignment — before more advanced arthritis narrows the range of realistic options.

What counts as early knee osteoarthritis

Put more simply than the research labels, early knee osteoarthritis is the stage where a knee has started to behave like an arthritic joint, but has not yet reached the obvious X-ray appearance of established arthritis. Researchers use that idea to describe a grey zone rather than a neat cut-off. In a 2020 classification study, people were typically counted as early-stage if the X-ray showed Kellgren–Lawrence grade 0 or I, symptoms were present enough for at least 2 of 4 KOOS subscales to score 85 or below, and examination found at least one sign such as joint-line tenderness or crepitus. That is helpful for research, but it is not a universal clinical rulebook.

Imaging adds context, but it is only one part of the diagnosis. MRI can reveal change earlier than a plain radiograph, and newer compositional MRI techniques may detect biochemical cartilage change before a clear cartilage defect appears. Even so, there is still no universally accepted MRI definition of early knee OA, and these advanced scans are not yet standardised for routine practice. In real clinics, “early” sits between a fully healthy knee and established arthritis, with symptoms, examination and imaging each contributing part of the picture.

Could it be something other than osteoarthritis

Instead of treating every early ache as “probably OA”, the safer clinical starting point is differential diagnosis. In the 2025 OARSI work on early symptomatic knee osteoarthritis, clinicians highlighted meniscal pathology, patellofemoral pain, collateral ligament injury, immune-mediated arthritis and crystal arthritis as important alternatives. That overlap is one reason early knee symptoms can be misleading: pain, stiffness, swelling and crepitus are common osteoarthritis anchors, but they are not unique to osteoarthritis.

Small details often change the picture. “Catching”, “giving way”, the exact pain location, whether swelling came on suddenly or gradually, and when symptoms are worst can all shift the likely diagnosis between a meniscal problem, patellofemoral overload, ligament-related instability or an inflammatory cause. A scan may add useful clues, but a structural finding on MRI is not automatically the pain source, and some symptomatic knees still show little on an early X-ray or a non-specific report. The practical consequence is simple: the pathway towards rehabilitation, injections, joint-preserving surgery or replacement depends on getting the diagnosis right first.

How a specialist works out what stage you are at

Two people can report the same “aching” or “crackling” knee and still land in different stages once a specialist separates the history, the examination and the imaging. The symptom pattern is the first layer: pain, stiffness, swelling, tenderness, reduced movement, and a grating or crackling sensation are common osteoarthritis features. Those clues matter, but they do not stage the knee on their own, and they do not prove OA.

The next step is the clinical examination. In the 2020 early-stage classification work, joint-line tenderness or crepitus counted as relevant findings; in day-to-day practice, the examination also looks for effusion, loss of range of motion, limb alignment, patellofemoral provocation, and signs of instability. That is where two similar symptom stories may separate: one knee may behave like early degenerative change, while another looks more meniscal, patellofemoral, ligament-related, inflammatory, or crystal-driven.

Imaging then answers a different question. Plain X-rays, often taken weight-bearing, help show whether there is already established arthritis or only slight radiographic change such as Kellgren–Lawrence 0-I. MRI is usually more useful when the X-ray looks relatively mild but symptoms or examination suggest a focal cartilage lesion, meniscal pathology, or another intra-articular problem. Imaging can detect earlier degeneration than radiographs, but it still has to be read alongside the history and examination.

The point of staging is practical. A knee with mild radiographic change and a localised mechanical problem may still sit in a preservation-focused pathway; a knee with more advanced structural disease and longstanding functional loss may move towards symptom-control measures and, in some cases, eventual replacement planning.

What to do first if your symptoms are still early

For most people, the first step is not a procedure but a calmer loading pattern. Early management usually means cutting back the activities that reliably flare the knee, then building back with targeted physiotherapy, strength work and movement control rather than trying to “push through” every painful session. In day-to-day terms, that often means adjusting stairs, squatting, hill walking, running volume or court sport for a period. Pain relief may help keep rehabilitation possible, but a “quieter” knee is not the same as a problem that has been corrected.

Unloading becomes relevant only in selected cases, especially when assessment suggests that alignment or load concentration is part of the picture. In a 2025 systematic review, both invasive and non-invasive unloading methods improved indicators of knee loading, but non-invasive approaches still lacked strong structural evidence such as cartilage-volume or joint-space change. The practical payoff, when unloading does help, is usually simpler than the biomechanics language: less pain on stairs, less swelling after a walk, and better tolerance of ordinary daily load.

Progress is better judged by a few repeatable markers: whether pain settles by the next morning, whether swelling is less frequent, how the knee copes with walking, stairs and getting up from a chair, and whether function is widening rather than shrinking. If symptoms keep returning, start limiting work, commuting or exercise, or fail to improve despite appropriate early management, that is the point for reassessment rather than endless self-management.

When joint preservation is realistic and when it is not

By the time joint preservation is being discussed, selection matters more than optimism. In the published literature, these strategies are usually studied in earlier disease: mild-to-moderate osteoarthritis, focal cartilage damage, or knees where malalignment is concentrating load. A 2025 systematic review of unloading methods found biomechanical improvement with both invasive and non-invasive approaches, but the non-invasive studies still lacked strong structural evidence such as cartilage-volume or joint-space change. That is why the practical frame is a suitability question, not a universal treatment pitch.

The same pattern runs through scaffold and cell-based work. In one prospective scaffold series, 22 patients with a mean age of 39 and Kellgren–Lawrence 0-I-II changes plus focal cartilage abnormalities improved clinically at 5 years, yet activity did not return to pre-injury levels and comprehensive failure was 16.6%. An ESSKA systematic review of mesenchymal stem cell implantation in mild-to-moderate knee OA also reported short-term clinical improvement and satisfactory cartilage restoration, but described the evidence as limited and heterogeneous. Those signals are encouraging for selected knees; they do not show that preservation reliably stops long-term progression in every arthritic knee.

The other side of the line is plainer. Once structural change is more diffuse, pain and function loss are more established, and the knee is moving towards end-stage arthritis rather than a localised defect, preservation options become less realistic and replacement enters the conversation more often. A specialist cartilage assessment may still clarify whether there is a focal repairable lesion within an otherwise earlier-stage knee. In that narrower part of the pathway, Liquid Cartilage™ may be considered as one downstream cartilage-repair option after assessment, rather than as an answer to advanced, generalised osteoarthritis.

1. [1] Early knee OA definition–what do we know at this stage? An imaging perspective. (2023). https://doi.org/10.1177/1759720X231158204 https://doi.org/10.1177/1759720X231158204
2. [2] Towards classification criteria for early-stage knee osteoarthritis: A population-based study to enrich for progressors. (2020). https://doi.org/10.1016/j.semarthrit.2020.11.002 https://doi.org/10.1016/j.semarthrit.2020.11.002